FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: December 27, 1996
VIVRA INCORPORATED
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-10261 94-3096645
- -------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Id. No.)
incorporation)
1850 Gateway Drive, Suite 500, San Mateo, California 94404
- -------------------------------------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (415) 577-5700.
<PAGE>
Item 5. Other Events.
------------
Vivra Incorporated ("Vivra"), has received from the United States Attorney for
the District of Massachusetts a grand jury subpoena which calls for records
pertaining to the operations of Vivra Renal Care. The subpoena appears to focus
on Vivra's previous relationship with Damon Clinical Laboratories and other
affiliated entities (Damon), as well as utilization patterns and procedures
pertaining to clinical laboratory blood tests billed to the Medicare and/or
Medicaid programs. In connection with the receipt of this subpoena, Vivra has
been advised that Vivra Renal Care is now a subject of the United States
Attorney's investigation. Vivra will cooperate fully with the United States
Attorney in this investigation.
The government is seeking documents for the time period January 1, 1987 through
July 1, 1996 that pertain to every kidney dialysis facility owned, managed, or
operated by Vivra and affiliated entities, as well as all agreements and
communications with Damon. Subsequent to Vivra's spin-off from Community
Psychiatric Centers in late 1989, total lab receipts from Damon represented less
than 1% of VRC's total revenues.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: December 27, 1996
VIVRA INCORPORATED
By /s/ LEANNE M. ZUMWALT
------------------------------------
Leanne M. Zumwalt
Executive Vice President
